Riboflavin and Photophobia - a phase IV clinical study of FDA data

Summary:

Photophobia is reported as a side effect among people who take Riboflavin (riboflavin (vitamin b2)), especially for people who are female, 30-39 old, also take Topiramate, and have Acute lymphocytic leukaemia (in remission).

The phase IV clinical study analyzes which people have Photophobia when taking Riboflavin. It is created by eHealthMe based on reports of 2,771 people who have side effects when taking Riboflavin from the FDA, and is updated regularly.

What is Riboflavin?

Riboflavin has active ingredients of riboflavin (vitamin b2). It is often used in migraine. eHealthMe is studying from 2,869 Riboflavin users. Check the latest studies of Riboflavin.

What is Photophobia?

Photophobia (extreme sensitivity to light) is found to be associated with 1,288 drugs and 1,831 conditions by eHealthMe. Check the latest studies of Photophobia.

On Jul, 30, 2026

2,771 people reported to have side effects when taking Riboflavin.
Among them, 26 people (0.94%) have Photophobia.

Among these 26 people:

What is the gender of people who have Photophobia when taking Riboflavin? *

female: 52.38 %
male: 47.62 %

What is the age of people who have Photophobia when taking Riboflavin? *

What are other drugs people take besides Riboflavin? *

What are other side effects people have besides Photophobia? *

Drug Ineffective: 15 people, 57.69%
Drug Intolerance (drug sensitivity): 15 people, 57.69%
Headache (pain in head): 13 people, 50.00%
Hemianopia Homonymous (visual field defect involving either the two right or the two left halves of the visual fields of both eyes): 12 people, 46.15%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 6 people, 23.08%
Neck Pain: 6 people, 23.08%
Neuropathy Peripheral (surface nerve damage): 5 people, 19.23%
Nausea (feeling of having an urge to vomit): 5 people, 19.23%
Sinusitis (inflammation of sinus): 5 people, 19.23%
Fatigue (feeling of tiredness): 5 people, 19.23%

What are the existing conditions these people have? *

Acute Lymphocytic Leukaemia (In Remission): 3 people, 11.54%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 7.69%
Stable Angina (a constant chest pain): 1 person, 3.85%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 3.85%
Pharyngitis Streptococcal (inflammation of the pharynx caused by infection from. streptococcus): 1 person, 3.85%
Neuralgia (pain in one or more nerves): 1 person, 3.85%
Migraine With Aura (headache with vision weakness): 1 person, 3.85%
High Blood Pressure: 1 person, 3.85%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 3.85%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Riboflavin and have Photophobia?

- Check whether Photophobia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Riboflavin:

Riboflavin (2,869 reports)

Photophobia treatments and more:

Photophobia (21,346 reports)

Browse all side effects of Riboflavin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Photophobia:

Photophobia (1,288 drugs)

Browse all the conditions that are associated with Photophobia:

Photophobia (1,831 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on riboflavin (vitamin b2) (the active ingredients of Riboflavin) and Riboflavin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.